In 2013, it announced its financial performance including revenues of £104 million ($178 million). This year, the company has made several personnel appointments and restructured its investor base. In February 2014, the company announced in a press release that it partnered with Karolinska Development of Sweden, a life science development company that licenses or sells innovative products. The company has over 1,600 employees in 40 countries including the U.S. Two years ago, Ockham acquired Nexus Oncology, a Scotland-based oncology CRO.Ĭhiltern is a UK-based company with 30 years of experience as a CRO. Growing out of questions about the nexus between theory and literature. In May, the company announced that it developed a software system with Mindprint to help manage the operational complexity of clinical trials. Slotemaker published Ockham and Ockhamism. Ockham’s European headquarters are located in Roslin, Scotland, and the company has offices around the world. The company was founded in 1986 and employs 300 people according to a regional newspaper, the Triangle Business Journal. This comes just after a couple of weeks after Android 4.4.3 was released.Not sure what Google has fixed or included in this new update, bu the factory images for the Nexus family of devices can now be downloaded for manual flashing on your phone/tablet. Ockham operates from its headquarters in Cary, North Carolina. Android 4.4.4 KTU84P is already now available for download. Chiltern will also function as a Global Functional Service Provider (FSP) and provide custom solutions for clinical and regulatory requirements. The two companies intend to leverage each other’s service offerings in strategic areas including oncology, respiratory, ophthalmology, infectious disease, vaccines, and dermatology. He added, “We are fortunate to have found the ideal partner with a complete understanding and commitment to the unique needs of our emerging biotech clientele.”Ĭhiltern has acquired 100 percent of Ockham, whose management team including Mr. Baker, CDO of the newly combined business Chiltern, said that the merger was an easy choice due to Chiltern’s global reach and presence in Europe. James Esinhart, CEO of Chiltern, said, “This merger is a natural progression towards our strategic goal of becoming the premier specialized mid-tier CRO.” The companies expect that this merger will strengthen service offerings as it is bringing together the scientific and management team of Ockham with Chiltern.ĭr. The two will merge operations into a combined company that will be called Chiltern. Chiltern, a contract research organization (CRO), announced in a press release that it has acquired Ockham, a CRO.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |